Analyst Research

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

MiMedx Group Inc Reaffirms FY 2013 Revenue Guidance; Issues Q3 2013 Revenue Guidance In Line With Analysts' Estimates


Wednesday, 31 Jul 2013 07:00am EDT 

MiMedx Group Inc announced that it has reaffirmed its previously communicated revenue guidance for fiscal 2013 to be in the range of $54 million to $60 million. The Company's goals for the third quarter of 2013 are for revenue to be in the range of $13.5 million to $16.0 million. According to I/B/E/S Estimates, analysts are expecting the Company to report revenues of $58 million for fiscal 2013; revenues of $15.1 for the third quarter of 2013. 

Company Quote

9.15
0.03 +0.33%
11:54am EDT